Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)

NCT01214434 is registered in ClinicalTrials.gov with Promius Pharma, LLC as lead sponsor.

NCT NCT01214434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01214434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)
Lead sponsor
Promius Pharma, LLC
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
June 30, 2011
Enrollment
42 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cradle cap, infantile seborrheic dermatitis